These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2528885)

  • 21. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
    Walch L; de Montpreville V; Brink C; Norel X
    Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of myocardial damage and polymorphonuclear leukocyte accumulation following coronary artery occlusion and reperfusion by the thromboxane receptor antagonist BM 13.505.
    Griswold DE; Egan JW; Earl CQ; Hillegass LM; Marshall PJ; Smith EF
    Prog Clin Biol Res; 1989; 301():161-5. PubMed ID: 2529547
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of the new thromboxane A2 antagonist vapiprost on isolated canine blood vessels.
    Matsuzaki T; Noguchi K; Nakasone J; Uezu K; Higuchi M; Sakanashi M
    Arzneimittelforschung; 1992 Nov; 42(11):1318-22. PubMed ID: 1492844
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Hydroxytryptamine contracts human coronary arteries predominantly via 5-HT2 receptor activation.
    Connor HE; Feniuk W; Humphrey PP
    Eur J Pharmacol; 1989 Feb; 161(1):91-4. PubMed ID: 2542039
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Glibenclamide is a competitive antagonist of the thromboxane A2 receptor in dog coronary artery in vitro.
    Cocks TM; King SJ; Angus JA
    Br J Pharmacol; 1990 Jun; 100(2):375-8. PubMed ID: 2143093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 8-Epi-PGF2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro.
    Kawikova I; Barnes PJ; Takahashi T; Tadjkarimi S; Yacoub MH; Belvisi MG
    Am J Respir Crit Care Med; 1996 Feb; 153(2):590-6. PubMed ID: 8564103
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of group B Streptococcus on the responses to U46619, endothelin-1, and noradrenaline in isolated pulmonary and mesenteric arteries of piglets.
    Villamor E; Pérez Vizcaíno F; Tamargo J; Moro M
    Pediatr Res; 1996 Dec; 40(6):827-33. PubMed ID: 8947958
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RS-61756-007: a potent and selective thromboxane receptor (TP) agonist.
    Eglen RM; Whiting RL
    J Pharm Pharmacol; 1989 May; 41(5):347-9. PubMed ID: 2569526
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of SK&F 95587 and BN 50730 on bronchoconstrictor responses in the cat.
    Dyson MC; Bellan JA; Minkes RK; Beckerman RC; Wegmann MJ; Braquet P; McNamara DB; Kadowitz PJ
    J Pharmacol Exp Ther; 1990 Dec; 255(3):1320-7. PubMed ID: 2175802
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
    Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
    Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relaxant and contractile effects of some amines and prostanoids in myometrial and vascular smooth muscle within the human uteroplacental unit.
    Maigaard S; Forman A; Andersson KE
    Acta Physiol Scand; 1986 Sep; 128(1):33-40. PubMed ID: 3766173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional antagonism in rabbit pulmonary veins contracted by endothelin.
    Russell JA; Roberts JM
    Pulm Pharmacol; 1991; 4(2):67-72. PubMed ID: 1666530
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
    Yin K; Halushka PV; Yan YT; Wong PY
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacological actions of ICI 180080, a novel thromboxane receptor antagonist.
    Jessup CL; Jessup R; Wayne M
    J Pharm Pharmacol; 1986 Oct; 38(10):754-7. PubMed ID: 2878996
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antagonism of prostanoid-induced vascular contraction by 13-azaprostanoic acid (13-APA).
    Horn PT; Kohli JD; LeBreton GC; Venton DL
    J Cardiovasc Pharmacol; 1984; 6(4):609-13. PubMed ID: 6206314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of the thromboxane-receptor antagonists AH 23848 and BM 13.177 on human uteroplacental arteries.
    Svane D; Skajaa K; Andersson KE; Forman A
    Obstet Gynecol; 1992 Aug; 80(2):234-40. PubMed ID: 1386150
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Calcium antagonistic and spasmolytic activities of a new 1,5-benzothiazepine derivative in isolated canine and monkey arteries.
    Kikkawa K; Murata S; Nagao T
    Arzneimittelforschung; 1988 Apr; 38(4):526-31. PubMed ID: 3165267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of ridogrel on vascular contractions caused by vasoactive substances released during platelet activation.
    Janssens WJ; Cools FJ; Hoskens LA; Van Nueten JM
    Thromb Haemost; 1990 Aug; 64(1):91-6. PubMed ID: 2148850
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacologic characterization of human and canine thromboxane A2/prostaglandin H2 receptors in platelets and blood vessels: evidence for different receptors.
    Mais DE; Saussy DL; Chaikhouni A; Kochel PJ; Knapp DR; Hamanaka N; Halushka PV
    J Pharmacol Exp Ther; 1985 May; 233(2):418-24. PubMed ID: 2987481
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pre- and postjunctional effects of some prostanoids in human isolated vas deferens.
    Holmquist F; Hedlund H; Andersson KE
    Am J Physiol; 1991 Apr; 260(4 Pt 2):R792-7. PubMed ID: 1707245
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.